HopeStage
Back to all studies
RecruitingNCT07192367

Virtual reality exposure therapy or sertraline for social anxiety

About this titleRead the official source — NCT07192367

This study evaluates the effectiveness of virtual reality therapy for people with anxiety.

Medication studyAges 12–17Türkiye
The study in practice

Understand this study

What is this study about?

This study evaluates the effectiveness of virtual reality therapy for people with anxiety.

Who could participate?

Listed age limits: 12 years to 17 years.

Listed locations
KocaeliSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 15, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
56
Sponsor
Emine Kanmaz
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Behavioural, Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Türkiye
Age range
From 12 Years to 17 Years
Official registry ID
NCT07192367
Official title
Show the full official title

Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder

Recruitment & locations

Currently recruiting

Kocaeli, Türkiye · Türkiye

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

This study evaluates the effectiveness of virtual reality therapy for people with anxiety.

Who is behind this study?

The study sponsor is Emine Kanmaz.

Does this study involve medication?

Yes. The study involves medication, including Sertraline (Oral Antidepressant).

Who can participate?

Listed age limits: 12 years to 17 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies